Regulation of small GTPase activity by G1 cyclins.


Journal

Small GTPases
ISSN: 2154-1256
Titre abrégé: Small GTPases
Pays: United States
ID NLM: 101530974

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 28 1 2017
medline: 5 3 2019
entrez: 28 1 2017
Statut: ppublish

Résumé

Together with a cyclin-dependent kinase (CDK) partner G1 cyclins control cell cycle entry by phosphorylating a number of nuclear targets and releasing a transcriptional program at the end of G1 phase. Yeast G1 cyclins also operate on cytoplasmic targets involved in the polarization of the cytoskeleton and vesicle trafficking. These processes are mainly controlled by the small GTPase Cdc42, and G1 cyclins regulate the activity of this and other small GTPases through the modulation of their regulators and effectors. This regulation is key for different developmental outcomes in unicellular organisms. In mammalian cells cytoplasmic G1 cyclin D1 has been shown to promote the activity of Rac1 and Ral GTPases and to block RhoA. Regulation of these small GTPases by G1 cyclins may constitute a mechanism to coordinate proliferation with cell migration and morphogenesis, important processes not only during normal development and organogenesis but also for tumor formation and metastasis. Here we briefly review the evidence supporting a role of G1 cyclins and CDKs as regulators of the activity of small GTPases, emphasizing their functional relevance both in budding yeast and in mammalian cells.

Identifiants

pubmed: 28129038
doi: 10.1080/21541248.2016.1268665
pmc: PMC6343608
doi:

Substances chimiques

Cyclin G1 0
Monomeric GTP-Binding Proteins EC 3.6.5.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

47-53

Références

Nat Commun. 2016 May 16;7:11581
pubmed: 27181366
Nat Cell Biol. 2004 Jan;6(1):59-66
pubmed: 14688790
J Cell Sci. 2004 Mar 15;117(Pt 8):1291-300
pubmed: 15020669
Science. 2009 Sep 25;325(5948):1682-6
pubmed: 19779198
Mol Cell Biol. 2006 Jun;26(11):4240-56
pubmed: 16705174
Curr Opin Cell Biol. 2013 Dec;25(6):717-23
pubmed: 23916770
Clin Cancer Res. 2000 May;6(5):1891-5
pubmed: 10815912
J Cell Biol. 2000 Mar 20;148(6):1115-22
pubmed: 10725324
J Cell Biol. 1984 Mar;98(3):934-45
pubmed: 6365931
Cancer Res. 2006 Oct 15;66(20):9986-94
pubmed: 17047061
Mol Cell. 2004 Oct 22;16(2):257-67
pubmed: 15494312
Nat Cell Biol. 2007 May;9(5):506-15
pubmed: 17417630
Oncogene. 2011 Apr 21;30(16):1936-46
pubmed: 21242975
Mol Microbiol. 2006 Jan;59(2):567-78
pubmed: 16390450
Mol Biol Cell. 2009 Jul;20(14):3239-50
pubmed: 19458192
Small GTPases. 2010 Jul;1(1):69-74
pubmed: 21686122
J Cell Biol. 1981 Jun;89(3):395-405
pubmed: 7019215
Mol Biol Cell. 2007 Jan;18(1):265-81
pubmed: 17093060
Cell Signal. 2008 Nov;20(11):2002-12
pubmed: 18713649
Nature. 2003 Oct 23;425(6960):859-64
pubmed: 14574415
Nature. 2002 Dec 12;420(6916):629-35
pubmed: 12478284
Genes Dev. 2006 Jan 1;20(1):47-64
pubmed: 16391232
Mol Biol Cell. 2008 Apr;19(4):1763-71
pubmed: 18256282
Mol Cell. 2004 Jun 18;14(6):699-711
pubmed: 15200949
Exp Cell Res. 2016 Apr 10;343(1):14-20
pubmed: 26519907
J Cell Sci. 2008 Sep 1;121(Pt 17):2824-32
pubmed: 18682498
Nat Rev Mol Cell Biol. 2016 May;17(5):280-92
pubmed: 27033256
Genes Dev. 2004 Apr 15;18(8):862-76
pubmed: 15078817
Nat Rev Cancer. 2008 Feb;8(2):133-40
pubmed: 18219307
PLoS One. 2009 Aug 10;4(8):e6563
pubmed: 19668330
Genome Biol. 2014;15(6):122
pubmed: 25180339
Curr Biol. 2015 Feb 2;25(3):316-325
pubmed: 25619768
Trends Microbiol. 2004 Jul;12(7):317-24
pubmed: 15223059
Mol Cell. 2000 Nov;6(5):1155-67
pubmed: 11106754
EMBO J. 2010 Sep 1;29(17):2930-42
pubmed: 20639857
Genetics. 2012 Jan;190(1):51-77
pubmed: 22219508
J Cell Sci. 2008 Aug 1;121(Pt 15):2435-44
pubmed: 18650496
Genes Dev. 2005 Nov 1;19(21):2606-18
pubmed: 16230527
EMBO J. 2007 Oct 31;26(21):4487-500
pubmed: 17853895
Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10762-7
pubmed: 18669648
PLoS One. 2015 Apr 10;10(4):e0123326
pubmed: 25860339
EMBO J. 2007 Aug 22;26(16):3760-9
pubmed: 17673907
Nat Cell Biol. 2000 Feb;2(2):117-24
pubmed: 10655592
Nature. 2009 Sep 3;461(7260):99-103
pubmed: 19693013
EMBO J. 2007 Oct 31;26(21):4501-13
pubmed: 17914457

Auteurs

Neus Pedraza (N)

a Cell Cycle Lab, Institut de Recerca Biomèdica de Lleida (IRBLleida) , and Departament de Ciències Mèdiques Bàsiques , Facultat de Medicina, Universitat de Lleida , Lleida , Catalonia , Spain.

Tània Cemeli (T)

a Cell Cycle Lab, Institut de Recerca Biomèdica de Lleida (IRBLleida) , and Departament de Ciències Mèdiques Bàsiques , Facultat de Medicina, Universitat de Lleida , Lleida , Catalonia , Spain.

Ma Ventura Monserrat (MV)

a Cell Cycle Lab, Institut de Recerca Biomèdica de Lleida (IRBLleida) , and Departament de Ciències Mèdiques Bàsiques , Facultat de Medicina, Universitat de Lleida , Lleida , Catalonia , Spain.

Eloi Garí (E)

a Cell Cycle Lab, Institut de Recerca Biomèdica de Lleida (IRBLleida) , and Departament de Ciències Mèdiques Bàsiques , Facultat de Medicina, Universitat de Lleida , Lleida , Catalonia , Spain.

Francisco Ferrezuelo (F)

a Cell Cycle Lab, Institut de Recerca Biomèdica de Lleida (IRBLleida) , and Departament de Ciències Mèdiques Bàsiques , Facultat de Medicina, Universitat de Lleida , Lleida , Catalonia , Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH